Best in Biotech 21 Mar 2023 5 advancements in Down syndrome research over the past year …profile of the unmet medical need for individuals with Down syndrome and managing Alzheimer’s disease from which they almost invariably suffer.” New drug could target Alzheimer’s disease in people with… March 21, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 7 Feb 2020 EU Project Set up to Fight Alzheimer’s Disease with Lasers A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s and Huntington’s disease by making brain cells controllable with red light. There are currently no… February 7, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 6 Apr 2017 Biotech Targeting Tau-Tangles in Neurodegeneration Initiates Clinical Trials …commented Beher. Formation of Tau aggregates in Tauopathies and Alzheimer’s. Under healthy conditions, the tau protein stabilizes microtubuli within the neurons. Neurodegenerative diseases such as Alzheimer’s have gained increasing attention… April 6, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Dec 2023 Wrapping up 2023: A recap of top biotech moments of this year …opened new doors in Alzheimer’s research, providing a foundation for future innovations. The success of LEQEMBI and the progress in vaccine development have reignited interest in Alzheimer’s research, with potential… December 20, 2023 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 27 Sep 2016 Another “Almost” against Alzheimers: Lundbeck’s Phase III Flop Alzheimer’s Disease is the most common form of dementia, affecting 15M people across the world. With the most recent failure of idalopirdine, a cure will remain elusive for now. As… September 27, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 1 Aug 2024 European regulators reject Alzheimer’s drug Leqembi: is it downhill from here? …the CHMP’s negative opinion and understand that this may also be disappointing for the wider Alzheimer’s disease community. Alzheimer’s disease is an irreversible, neurodegenerative disease that poses significant challenges to… August 1, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2018 Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease …as Parkinson’s and Alzheimer’s and even traumatic brain injury. The German biotech Hummingbird Diagnostics is developing liquid biopsies that detect miRNA strands involved in Alzheimer’s and Parkinson’s disease. Back in… June 14, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Podcast 15 Dec 2023 Vaxxinity making vaccines to change the world …being able to go and get an Alzheimer’s vaccine when you’re 40 or 50… so that even though you would have maybe gotten Alzheimer’s at 60, you’re pushing it away… December 15, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 24 Sep 2025 Eli Lilly’s strategy in motion: Beyond diabetes and obesity …headline-grabbing science with targeted dealmaking: it secured full U.S. Food and Drug Administration (FDA) approval for its Alzheimer’s drug Kisunla (donanemab) in July 2024, marking a major step in neurodegeneration,… September 24, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 29 Sep 2022 Positive results from Eisai and Biogen Alzheimer’s trial …due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD) with confirmed presence of amyloid pathology in the brain. Lecanemab is an investigational anti-amyloid beta (Aβ) protofibril… September 29, 2022 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2016 What Does ‘Anti-Aging Treatment’ Mean in Biotech? …a much tougher battle. We need to go as early as possible, before the disease begins to impact a patient.” A hallmark of Alzheimer’s is the development of amyloid beta… December 20, 2016 - 5 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 30 May 2023 New study reveals Alzheimer’s inflammation protection A possible explanation has been found in a study for why apoE4, the most significant genetic risk factor associated with Alzheimer’s disease, fails to protect the brain from inflammation. Alzheimer’s… May 30, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email